Whilst straight lining the trial costs may be a reasonable surrogate I would imagine trial costs are front loaded and/or milestone/recruitment based so a bit more "lumpy" and hard to predict (particularly around recruitment). Just to manage expectations. Great if you get some guidance....
Race Oncology - Cashflow Forecast to December 2024, page-9
-
- There are more pages in this discussion • 3 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RAC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.66 |
Change
0.025(1.53%) |
Mkt cap ! $282.7M | |||
| Open | High | Low | Value | Volume |
| $1.66 | $1.69 | $1.58 | $350.6K | 215.5K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1000 | $1.63 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.66 | 2493 | 1 |
View Market Depth
| Last trade - 16.10pm 25/07/2024 (20 minute delay) ? |
| RAC (ASX) Chart |